Giovannetti E - Search Results

1

Genetic variation: effect on prostate cancer.

Sissung TM, Price DK, Del Re M, Ley AM, Giovannetti E, Figg WD, Danesi R. Sissung TM, et al. Among authors: giovannetti e. Biochim Biophys Acta. 2014 Dec;1846(2):446-56. doi: 10.1016/j.bbcan.2014.08.007. Epub 2014 Sep 6. Biochim Biophys Acta. 2014. PMID: 25199985 Free PMC article. Review.

2

Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity.

Macchia M, Antonello M, Bertini S, Di Bussolo V, Fogli S, Giovannetti E, Minutolo F, Rapposelli S, Danesi R. Macchia M, et al. Among authors: giovannetti e. Farmaco. 2003 Jan;58(1):85-9. doi: 10.1016/S0014-827X(02)00002-2. Farmaco. 2003. PMID: 12595041

3

Ceramide analogues in apoptosis: a new strategy for anticancer drug development.

Macchia M, Bertini S, Fogli S, Giovannetti E, Minutolo F, Rapposelli S, Danesi R. Macchia M, et al. Among authors: giovannetti e. Farmaco. 2003 Mar;58(3):205-11. doi: 10.1016/S0014-827X(03)00015-6. Farmaco. 2003. PMID: 12620416 Review.

4

Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.

Giovannetti E, Mey V, Danesi R, Mosca I, Del Tacca M. Giovannetti E, et al. Clin Cancer Res. 2004 May 1;10(9):2936-43. doi: 10.1158/1078-0432.ccr-03-0520. Clin Cancer Res. 2004. PMID: 15131028

5

Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.

Giovannetti E, Mey V, Danesi R, Basolo F, Barachini S, Deri M, Del Tacca M. Giovannetti E, et al. Br J Cancer. 2005 Feb 28;92(4):681-9. doi: 10.1038/sj.bjc.6602382. Br J Cancer. 2005. PMID: 15700043 Free PMC article.

6

Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.

Giovannetti E, Mey V, Nannizzi S, Pasqualetti G, Marini L, Del Tacca M, Danesi R. Giovannetti E, et al. Mol Pharmacol. 2005 Jul;68(1):110-8. doi: 10.1124/mol.104.009373. Epub 2005 Mar 28. Mol Pharmacol. 2005. PMID: 15795320

7

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

Giovannetti E, Del Tacca M, Mey V, Funel N, Nannizzi S, Ricci S, Orlandini C, Boggi U, Campani D, Del Chiaro M, Iannopollo M, Bevilacqua G, Mosca F, Danesi R. Giovannetti E, et al. Cancer Res. 2006 Apr 1;66(7):3928-35. doi: 10.1158/0008-5472.CAN-05-4203. Cancer Res. 2006. PMID: 16585222

8

In vitro studies on gemcitabine combinations with other antiblastics.

Giovannetti E, Danesi R, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M. Giovannetti E, et al. Ann Oncol. 2006 May;17 Suppl 5:v17-19. doi: 10.1093/annonc/mdj943. Ann Oncol. 2006. PMID: 16807450 Free article. Review.

9

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.

Giovannetti E, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M, Danesi R. Giovannetti E, et al. Mol Cancer Ther. 2006 Jun;5(6):1387-95. doi: 10.1158/1535-7163.MCT-06-0004. Mol Cancer Ther. 2006. PMID: 16818496 Review.

10

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

Mey V, Giovannetti E, De Braud F, Nannizzi S, Curigliano G, Verweij F, De Cobelli O, Pece S, Del Tacca M, Danesi R. Mey V, et al. Among authors: giovannetti e. Br J Cancer. 2006 Aug 7;95(3):289-97. doi: 10.1038/sj.bjc.6603242. Epub 2006 Jul 25. Br J Cancer. 2006. PMID: 16868547 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters